LivaNova PE ratio LIVN

Share price divided by earnings per share over the last twelve months, since 2017.

Today, Oct 23, 2026: 23.9×
9-year median: 72.5×
Against its 9-year history: 10th; percentile: 0 is its lowest day, 100 its highest
9-year range: 22.1× to 175×
Peer median: 25.3×

LivaNova's PE ratio is 23.9× as of Oct 23, 2026: a share price of $80.90 against $3.39 of earnings per share over the last twelve months.

That is below its 9-year median of 72.5×, lower than on 90% of days in the last 9 years.

Over that time it ranged from 22.1× in Oct 2026 to 175× in Mar 2024.

The median for 6 medical device stocks of a similar size is 25.3×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	23.9×	22.1×	42.7×
2025	32.3×	29.8×	119×
2024	111×	111×	175×
2023	n/m a value too high to mean anything
2022	n/m a value too high to mean anything
2021	n/m a value too high to mean anything
2020	n/m a value too high to mean anything
2019	n/m a value too high to mean anything
2018	75.8×	69.8×	75.8×
2017	68.9×	68.2×	134×

Against its peers

Companies in Medical - Devices nearest LivaNova's size, closest first, today.

Company	PE ratio
LIVNLivaNova	23.9×
ITGRInteger	34.6×
TMDXTransMedics	18.4×
CNMDCONMED	26.6×
ZBHZimmer Biomet	24.0×
DXCMDexCom	30.9×
GEHCGE HealthCare Technologies	16.4×
Peer median	25.3×

Where LivaNova ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on LivaNova

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.